2023年5月15日

Autonomize AI -一個值得信賴的人工智能(AI)對衛生保健和生命科學公司——宣布關閉了一個400萬美元的種子輪來支持公司的人工智能平台的開發和擴展。和資產管理公司領導,參與的ATX Venture Partners,循環投資,和下一個實踐組。Autonomize AI會使用種子資金來提升其研發和商業化的努力。成立於2022年,Autonomize AI提供軟件產品來降低成本和提高操作效率為衛生保健和生命科學組織。產品包括:- Autonomize像素,通過更高效的工作流和最優協議加速臨床試驗設計、可行性研究和患者匹配。- Autonomize向導,增加臨床決策提供綜合圖表研究見解,付款人管理,注冊中心和決策。-生成AI提供會話、搜索和總結能力安全內部數據來源,更符合實際的為不同的用戶類型。Autonomize艾未未的解決方案是建立在一個安全的雲計算平台優化的醫療行業,支持多模式數據類型和利用pre-trained醫療大型語言模型(llm)。這些llm可能調整私人數據和部署到虛擬私有雲環境。加上Autonomize AI的隱私過濾器自動識別和匿名化個人身份信息和個人健康信息。 The company’s platform enables organizations to use AI capabilities without compromising patient data privacy and security. And by focusing on human-centered workflows, Autonomize AI is building the equivalent of the J.A.R.V.I.S. system (featured in Marvel’s Iron Man movies) for all healthcare workers to augment and empower their expertise. KEY QUOTES: “Despite the abundance of data and the availability of cutting-edge technology like AI, healthcare is broken for the patient. We are putting the patient back in the center of the healthcare ecosystem by empowering every knowledge worker with insights, content and context to do their best work and drive 100-times better patient outcomes. We are assembling some of the best scientists, researchers and engineers to solve this critical problem.” — Ganesh Padmanabhan, Autonomize AI founder and CEO “We believe that Autonomize AI holds the key to unlocking the vast potential of artificial intelligence in revolutionizing healthcare. While there is a lot of talk about AI in healthcare, extracting the insights buried within unstructured medical data in various silos is essential for fostering breakthroughs in patient care and overall health outcomes. We are thrilled to partner with this seasoned team, as they lead the charge in harnessing the power of AI to create a healthier future for all.” — Skip Fleshman, Asset Management Ventures General Partner “We evaluated several vendors building vertical solutions for patient matching and medical records review, but they offered limited solutions. Almost no existing platform consumes unstructured data and serves multiple contextual use cases. Autonomize AI has added tremendous value to SubjectWell in a short period of time by making our medical records review for clinical trials 10 times more efficient and accurate.” — Ivor Clarke, SubjectWell Chief Operating Officer Trending on Pulse 2.0